Clinical proteomics: Revolutionizing disease detection and patient tailoring therapy

被引:71
作者
Petricoin, E
Wulfkuhle, J
Espina, V
Liotta, LA
机构
[1] US FDA, NCI FDA Clin Proteom Program, Off Cell & Gene Therapy, Ctr Biol Evaluat & Res, Bethesda, MD 20892 USA
[2] NCI, NCI FDA Clin Proteom Program, Pathol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA
关键词
proteomics; pharmacoproteomics; patterns; mass spectrometry; protein microarrays;
D O I
10.1021/pr049972m
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The evolving discipline of Clinical Proteomics is more than simply describing and enumerating the systematic changes in the protein constituency of a cell, or just generating lists of proteins that increase or decrease in expression as a cause or consequence of disease. Clinical applications of proteomics involve the use of proteomic technologies at the bedside with the ultimate goal to characterize the information flow through the intra- and extracellular molecular protein networks that interconnect organ and circulatory systems together. These networks are both new targets for therapeutics themselves as well as underpin the dynamic changes that give rise to cascades of new diagnostic biomarkers. The analysis of human cancer can be used as a model for how clinical proteomics is having an impact at the bedside for early detection, rational therapeutic targeting, and patient-tailored therapy.
引用
收藏
页码:209 / 217
页数:9
相关论文
共 86 条
  • [1] Adam BL, 2001, PROTEOMICS, V1, P1264, DOI 10.1002/1615-9861(200110)1:10<1264::AID-PROT1264>3.0.CO
  • [2] 2-R
  • [3] Adam BL, 2002, CANCER RES, V62, P3609
  • [4] The human plasma proteome - History, character, and diagnostic prospects
    Anderson, NL
    Anderson, NG
    [J]. MOLECULAR & CELLULAR PROTEOMICS, 2002, 1 (11) : 845 - 867
  • [5] A RADIOIMMUNOASSAY USING A MONOCLONAL-ANTIBODY TO MONITOR THE COURSE OF EPITHELIAL OVARIAN-CANCER
    BAST, RC
    KLUG, TL
    STJOHN, E
    JENISON, E
    NILOFF, JM
    LAZARUS, H
    BERKOWITZ, RS
    LEAVITT, T
    GRIFFITHS, CT
    PARKER, L
    ZURAWSKI, VR
    KNAPP, RC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1983, 309 (15) : 883 - 887
  • [6] Oncogenic kinase signalling
    Blume-Jensen, P
    Hunter, T
    [J]. NATURE, 2001, 411 (6835) : 355 - 365
  • [7] Molecular networks: The top-down view
    Bray, D
    [J]. SCIENCE, 2003, 301 (5641) : 1864 - 1865
  • [8] Targeted therapy for malignant melanoma.
    Brown C.K.
    Kirkwood J.M.
    [J]. Current Oncology Reports, 2001, 3 (4) : 344 - 352
  • [9] Purification and characterization of the mammaglobin/lipophilin B complex, a promising diagnostic marker for breast cancer
    Carter, D
    Douglass, JF
    Cornellison, CD
    Retter, MW
    Johnson, JC
    Bennington, AA
    Fleming, TP
    Reed, SG
    Houghton, RL
    Diamond, DL
    Vedvick, TS
    [J]. BIOCHEMISTRY, 2002, 41 (21) : 6714 - 6722
  • [10] Cheng J D, 2000, Semin Oncol Nurs, V16, P2, DOI 10.1053/sonu.2000.19775